Zobrazeno 1 - 10
of 197
pro vyhledávání: '"J. De Castro Carpeño"'
Autor:
F Arias-Lotto, Patricia Cruz, S Martinez-Recio, L Gutierrez-Sainz, M I Esteban-Rodriguez, R A Gonzalez, Oliver Higuera, J De Castro-Carpeño
Publikováno v:
Clinical and Translational Oncology. 23:2030-2035
Malignant pleural mesothelioma (MPM) is a rare and aggressive tumor, with a poor prognosis. MPM needs to find prognostic factors of survival. We provided the management of patients with MPM and sought to determine whether pre-treatment levels of deri
Autor:
J. Villamayor, Eugenia Espinosa, J Pedregosa, Ana Custodio, Darío Sanchez-Cabrero, D. Viñal, Beatriz Castelo, L Gutierrez-Sainz, Virginia Martínez-Marín, P. Zamora, J A Garcia-Cuesta, Andrés Redondo, J de Castro-Carpeño, Alvaro Pinto, Oliver Higuera, J. Feliu, Patricia Cruz, A Gallego, D. Martinez-Perez
Publikováno v:
Clinical and Translational Oncology. 23:1245-1252
Cancer and cancer therapies have been associated with an increased incidence of venous thromboembolic events (VTE). However, the incidence of VTE in patients on immunotherapy has not been well characterized. The aim of this study was to assess the in
Autor:
P. Cruz Castellanos, R. Rosas Alonso, I. Ozaez, I. Hernández, I. Losantos, L. Gutiérrez Sainz, O. Higuera Gómez, C. Rodríguez Antolín, I. Esteban Rodríguez, I. Ibáñez de Cáceres, J. De Castro Carpeño
Publikováno v:
Journal of Thoracic Oncology. 17:S443-S444
Autor:
L. Gutiérrez Sainz, P. Cruz Castellanos, O. Higuera Gómez, T. López Fernández, B. Terol Espinosa de los Monteros, S. Valbuena López, A. Buño, E. Cuesta, E. Del Barco, E. Terán Brage, A. Martín García, R. Eiros Bachiller, C. Sánchez Pablo, N. Martínez Banaclocha, T. Lozano, I. Márquez Rodas, S. Pérez Ramírez, A. Calles Blanco, R. Álvarez, E. Zatarain Nicolás, J. De la Haba Rodríguez, P. Sánchez Mauriño, D. Mesa Rubio, F. Esteban Martínez, P. Martín Fernández, B. Ibáñez Cabeza, J. De Castro Carpeño
Publikováno v:
Journal of Thoracic Oncology. 17:S361-S362
Autor:
M. Casarrubios, A. Cruz-Bermúdez, B. Sierra-Rodero, C. Martinez, E. Nadal, V. Calvo, A. Insa, M.d.R. García- Campelo, C. Gonzalez Ojea, M. Dómine, M. Majem, D. Rodríguez-Abreu, A. Martínez-Martí, J. De Castro Carpeño, M. Cobo, G. López-Vivanco, E. Del Barco, R. Bernabé, B. Massutí, M. Provencio
Publikováno v:
Journal of Thoracic Oncology. 17:S6-S7
Autor:
L. Gutierrez-Sainz, S. López-Muñoz, P. Cruz-Castellanos, O. Higuera, M.I. Esteban-Rodríguez, I. Losantos-García, J. De Castro-Carpeño
Publikováno v:
ESMO Open. 7:100568
Tumor spread through air spaces (STAS) in lung adenocarcinoma is a novel mechanism of invasion. STAS has been proposed as an independent predictor of poor prognosis. The aim of this study was to evaluate the correlations between STAS status and other
Autor:
P. Cruz Castellanos, R. Rosas Alonso, I. Ozaez, I. Hernández, I. Losantos, L. Gutiérrez Sainz, O. Higuera Gómez, C. Rodríguez Antolín, I. Esteban Rodríguez, I. Ibáñez de Cáceres, J. De Castro Carpeño
Publikováno v:
Journal of Thoracic Oncology. 17:S558
Autor:
L, Gutierrez-Sainz, P, Cruz, S, Martinez-Recio, O, Higuera, M I, Esteban-Rodriguez, F, Arias-Lotto, R A, Gonzalez, J, De Castro-Carpeño
Publikováno v:
Clinicaltranslational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 23(10)
Malignant pleural mesothelioma (MPM) is a rare and aggressive tumor, with a poor prognosis. MPM needs to find prognostic factors of survival. We provided the management of patients with MPM and sought to determine whether pre-treatment levels of deri
Autor:
J de Castro-Carpeño, Joaquim Bosch-Barrera, Ernest Nadal, Ana Laura Ortega, M. Guirado, Rosario García-Campelo, D Vicente, J. Coves, Susana Cedres, R. López-Castro
Publikováno v:
Dipòsit Digital de la UB
Universidad de Barcelona
Scientia
CLINICAL & TRANSLATIONAL ONCOLOGY
r-FISABIO. Repositorio Institucional de Producción Científica
instname
Clinical & Translational Oncology
Universidad de Barcelona
Scientia
CLINICAL & TRANSLATIONAL ONCOLOGY
r-FISABIO. Repositorio Institucional de Producción Científica
instname
Clinical & Translational Oncology
Mesothelioma is a rare and aggressive tumour with dismal prognosis arising in the pleura and associated with asbestos exposure. Its incidence is on the rise worldwide. In selected patients with early-stage MPM, a maximal surgical cytoreduction in com
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57be013f2fef4c0aaf8c39391f3ff5ad
https://doi.org/10.1007/s12094-020-02532-2
https://doi.org/10.1007/s12094-020-02532-2
Autor:
L, Gutierrez-Sainz, V, Martinez-Marin, D, Viñal, D, Martinez-Perez, J, Pedregosa, J A, Garcia-Cuesta, J, Villamayor, P, Zamora, A, Pinto, A, Redondo, B, Castelo, P, Cruz, O, Higuera, A, Custodio, A, Gallego, D, Sanchez-Cabrero, J, de Castro-Carpeño, E, Espinosa, J, Feliu
Publikováno v:
Clinicaltranslational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 23(6)
Cancer and cancer therapies have been associated with an increased incidence of venous thromboembolic events (VTE). However, the incidence of VTE in patients on immunotherapy has not been well characterized. The aim of this study was to assess the in